Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Breimer

Showing results (261-270 of 360) with videos related to

Pageof 36
Sort By:
Journal of Clinical Pharmacology|August 1, 1989
Variability in the pharmacokinetics of nisoldipine as caused by differences in liver blood flow responseJ van Harten, P van Brummelen, P Ooms, et al.
Biochemical Pharmacology|November 15, 1984
Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in manC H Kleinbloesem, P van Brummelen, H Faber, et al.
Biopharmaceutics & Drug Disposition|January 1, 1986
Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administrationR Jochemsen, P A van Rijn, T G Hazelzet, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugsJ B van Bree, A G de Boer, M Danhof, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokineticsP A Soons, T M Mulders, E Uchida, et al.
British Journal of Clinical Pharmacology|February 1, 1991
Lack of pharmacokinetic interaction between nifedipine, sparteine and phenytoin in manJ H Schellens, P A Soons, J H van der Wart, et al.
Clinical Pharmacology and Therapeutics|June 1, 1992
Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteersJ W Mandema, B Tuk, A L van Steveninck, et al.
Anesthesiology|October 1, 1988
Pharmacokinetics of lidocaine and bupivacaine following subarachnoid administration in surgical patients: simultaneous investigation of absorption and disposition kinetics using stable isotopesA G Burm, J W Van Kleef, N P Vermeulen, et al.
Biomedical Mass Spectrometry|September 1, 1985
Selected ion monitoring analysis of pseudoracemic hexobarbital and its major metabolites in blood and urine of ratsM van der Graaff, P H Hofman, D D Breimer, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in miceS Desrayaud, E C De Lange, M Lemaire, et al.
Pageof 36

Showing results (261-270 of 360) with videos related to

Sort By:
Pageof 36
Journal of Clinical Pharmacology|August 1, 1989
Variability in the pharmacokinetics of nisoldipine as caused by differences in liver blood flow responseJ van Harten, P van Brummelen, P Ooms, et al.
Biochemical Pharmacology|November 15, 1984
Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in manC H Kleinbloesem, P van Brummelen, H Faber, et al.
Biopharmaceutics & Drug Disposition|January 1, 1986
Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administrationR Jochemsen, P A van Rijn, T G Hazelzet, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugsJ B van Bree, A G de Boer, M Danhof, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokineticsP A Soons, T M Mulders, E Uchida, et al.
British Journal of Clinical Pharmacology|February 1, 1991
Lack of pharmacokinetic interaction between nifedipine, sparteine and phenytoin in manJ H Schellens, P A Soons, J H van der Wart, et al.
Clinical Pharmacology and Therapeutics|June 1, 1992
Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteersJ W Mandema, B Tuk, A L van Steveninck, et al.
Anesthesiology|October 1, 1988
Pharmacokinetics of lidocaine and bupivacaine following subarachnoid administration in surgical patients: simultaneous investigation of absorption and disposition kinetics using stable isotopesA G Burm, J W Van Kleef, N P Vermeulen, et al.
Biomedical Mass Spectrometry|September 1, 1985
Selected ion monitoring analysis of pseudoracemic hexobarbital and its major metabolites in blood and urine of ratsM van der Graaff, P H Hofman, D D Breimer, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in miceS Desrayaud, E C De Lange, M Lemaire, et al.
Pageof 36